Key Players Shaping the GIST Therapeutics Market Growth
The global Gastrointestinal Stromal Tumor (GIST) therapeutics market is poised for significant growth over the next decade, with market value expected to rise from USD 1,000.0 million in 2025 to USD 1,790.9 million by 2035 , reflecting a compound annual growth rate (CAGR) of 6.0% . This expansion is being driven by advances in targeted therapies, increasing awareness of GIST, and growing patient access to specialized care. Rising Demand for Effective GIST Therapies GIST, a rare yet aggressive cancer affecting the digestive tract, continues to pose therapeutic challenges. The increasing incidence of GIST globally has amplified the demand for effective treatment options. Patients and healthcare providers are showing a growing preference for targeted therapies due to their precision, improved efficacy, and reduced systemic toxicity compared to conventional chemotherapy. Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16670 T...